🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
60% Evidence Coverage

Supplement Facts — Evidence Check

600 IU (150% DV)
✅ Within RDA (1.0× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.015000000000000001mg UL 0.1mg
Calcium
600 mg (60% DV)
378 mg (38% DV)
✅ Within RDA (0.5× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 378mg UL 4000mg
300 mg (75% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 300mg
MCHC
1500 mg

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Sodium Starch Glycolate Cellulose Stearic Acid Silica Coating

Label Claims — Verification

Nutrient
All Other
Approved Health
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

DIRECTIONS: Take three tablets daily or as directed by your healthcare practitioner.

⚠️ Warnings & Precautions

CAUTION: Keep out of the reach of children.

🧪 Formulation Notes

Cal Apatite(R) with Magnesium

Formulated to Exclude: Wheat, gluten, corn protein, soy, dairy products, nuts, tree nuts, fish, crustacean shellfish, colors, artificial sweeteners, and preservatives.

Complete Bone Nutrition with Magnesium

Additional Information

Cal Apatite with Magnesium features and exclusive; freeze-dried MCHC that ensures higher levels of intact bone growth factors than other MCHC formulas. This unique formula provides optimized levels of vitamin D and a blend of three forms of magnesium designed to be bioavailable to achieve a 2:1 calcium to magnesium ratio for comprehensive musculoskeletal support.

PROD. CA024

Genetic Potential Through Nutrition

PURITY CERTIFIED P THIRD PARTY ASSAYED

LCA02503 0110106 2/12

Product Details

UPC / SKU 7 55571 01305 7
DSLD Entry Date 2013-10-25
Product Type Other Combinations
Form Tablet or Pill
Brand Metagenics
DSLD ID 26518
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →